Strongbridge Biopharma (SBBP) director Kong returned to the company 63,993 shares

Insider transactions reported

Garheng Kong (director at Strongbridge Biopharma plc, SBBP) reported that they returned to the company 63,993 shares on Oct 5, 2021. After these transactions the filing shows 0 shares held directly.

Reporting person

Kong Garheng

Options and other derivatives

Holdings before and after

• Ordinary Shares: 63,993 to 0 direct
• Stock Option (Right to Buy): 154,385 to 0 direct

Footnotes from the filing

1. 1. Ordinary shares of Issuer were converted into shares of common stock of Xeris Biopharma Holdings, Inc. ( HoldCo ) pursuant to the Transaction Agreement (the Agreement ), dated May 24, 2021, among the Issuer, Xeris Pharmaceuticals, Inc., HoldCo and Wells MergerSub, Inc. Under the Agreement, each ordinary share of Issuer was exchanged for 0.784 of a share of HoldCo common stock, and cash in lieu of fractional shares, plus one contingent value right (a CVR ) worth up to an additional $1.00, payable in cash, HoldCo common stock or a combination thereof at HoldCo's sole election.
2. 2. Under the Agreement, each option to purchase ordinary shares of Issuer was automatically converted into an option to acquire a number of shares of HoldCo common stock determined by multiplying the number of ordinary shares of Issuer subject to such option by 0.784 (rounded down to the nearest whole share), at an exercise price per share (rounded up to the nearest whole cent) determined by dividing the per-share exercise price of Issuer option by 0.784, with the same terms and conditions as applied to the applicable option prior to closing of the transaction. HoldCo issued one CVR with respect to each ordinary share of Issuer subject to each option prior to the adjustment described herein, subject to the same vesting and forfeiture conditions applicable to the corresponding option.

Transaction codes in this filing

Sale back to the company:

Code D marks a disposition back to the company under an exempt plan, as opposed to a sale in the market.

FAQ